Company intelligence / Profile preview

Adir Group

Ownership: Private
Development stage: Other

Overview

Adir Group supplies advanced UV-C surface decontamination systems and HEPA-based air purification devices for infection prevention in healthcare environments. The group acts as a procurement partner representing leading manufacturers such as Surfacide and Airpura Industries. No drug development or clinical trial results.

Therapeutic areas: Infectious Diseases
Modalities: Non-pharmacological therapy (UV-C decontamination systems, HEPA filtration)Device
Industry: Therapeutic Medical Devices

Partnerships

Surfacide (Helios UV-C system)Airpura Industries (HEPA air purifiers)Sagol Advanced Technology (UV-C lamps/ballasts)

Beyond the preview

Go deeper on Adir Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adir Group.

Explore the full profile